Differences in the Clinical Outcome of XXXX by Treating Specialty: Orthopedics or Infectology.

@entity1 @entity4034 @entity166 @entity174
@entity4034 is a heterogeneous infection with regard to etiology and treatment, and currently no single management protocol exists. Management of the condition is typically an interdisciplinary approach between orthopedics and @entity166 ; however, the orthopedist is often the @entity1 who manages treatment. The aim of the study was to determine differences in the outcome of @entity4034 according to its treating specialty and to identify factors associated with the recurrence of the disease. An ambispective cohort study of 129 @entity1 with @entity4034 was conducted and the proportions for qualitative variables and central tendency and dispersion measures for quantitative variables were calculated; the latter were tested for normality using the Shapiro-Wilk test. A bivariate analysis was conducted with measures of association based on the chi square test and crude relative risk. A logistic regression model was applied and statistical significance was set at p < 0.05, including the model of relevant clinical variables that fit the Hosmer-Lemeshow test. We found that 70% of @entity1 were treated either by orthopedics or @entity166 . @entity1 who were treated by an orthopedist alone presented a greater risk of relapse or reinfection (RR = 4.6; 95% CI 2.3;8.9). Risk factors of @entity4034 as determined in the regression model included the following: age of 57 years or older (RR = 1.3; 95% 0.3;5.2), long bones (RR = 1.9; 95% CI 0.5;7.1), @entity174 (RR = 5.0; 95% CI 0.4;51.4), monotherapy (RR = 3.0; 95% CI 0.6;14.5), receiving less than 4 weeks of antibiotics (RR = 1.5; 95% CI 0.2;10.1), inadequate treatment (RR = 3.1; 95% CI 0.4;20.1), and receiving orthopedics treatment (RR = 5.5; 95% CI 1.6;18.2). Most @entity1 evaluated jointly by orthopedics and @entity166 received adequate treatment for @entity4034 and had fewer relapses.
